Although the interaction term in two-way ANOVA did not reach statistical significance (p = 0.243; n=5 per group), the collective evidence from multiple efficacy endpoints supports a cooperative effect of CCR8 blockade in enhancing the response to PD–L1 inhibition in the immunosuppressive EMT6 tumor model. The gene discussed is CCR8; the disease is neoplasm.